Eli Lilly and Co (XSWX:LLY) Cash Flow for Dividends: CHF-4,458 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:LLY Eli Lilly and Co XSWX:LLY
99 GF Score
Price CHF965.00
GF Value CHF1,133.11
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eli Lilly and Co Cash Flow for Dividends?

Eli Lilly and Co XSWX:LLY 99 Cash Flow for Dividends is CHF-4,458 Mil as of Mar. 2026. GuruFocus rates XSWX:LLY with a GF Score™ of 99/100 and a GF Value™ of CHF1,133.11 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Eli Lilly and Co's cash flow for dividends for the three months ended in Mar. 2026 was CHF-1,219 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-4,458 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Eli Lilly and Co's quarterly payment of dividends increased from Sep. 2025 (CHF-1,071 Mil) to Dec. 2025 (CHF-1,072 Mil) and increased from Dec. 2025 (CHF-1,072 Mil) to Mar. 2026 (CHF-1,219 Mil).

Eli Lilly and Co's annual payment of dividends increased from Dec. 2023 (CHF-3,519 Mil) to Dec. 2024 (CHF-4,173 Mil) and increased from Dec. 2024 (CHF-4,173 Mil) to Dec. 2025 (CHF-4,291 Mil).

Eli Lilly and Co Cash Flow for Dividends Related Terms

Eli Lilly and Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Cash Flow for Dividends Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,842.94 -3,293.95 -3,518.87 -4,172.69 -4,290.51

Eli Lilly and Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,189.33 -1,095.62 -1,070.91 -1,072.23 -1,218.74
XSWX:LLY
99GF Score
Eli Lilly and Co XSWX:LLY
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-4,458 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of CHF-4,458 Mil mean?
Eli Lilly and Co (XSWX:LLY) has a Cash Flow for Dividends of CHF-4,458 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Eli Lilly and Co and its competitors.
Is Eli Lilly and Co's Cash Flow for Dividends too high?
Eli Lilly and Co's current Cash Flow for Dividends is CHF-4,458 Mil. Overall, Eli Lilly and Co has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's Cash Flow for Dividends compare to JNJ and ABBV?
Eli Lilly and Co's Cash Flow for Dividends of CHF-4,458 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Eli Lilly and Co and its competitors. Eli Lilly and Co's current Cash Flow for Dividends is CHF-4,458 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Based on GuruFocus' analysis, Eli Lilly and Co (XSWX:LLY) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF1,133.11, compared to a current price of CHF965.00 — trading 14.8% below its estimated fair value. The current Cash Flow for Dividends is CHF-4,458 Mil. Eli Lilly and Co's overall GF Score™ is 99/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Eli Lilly and Co (XSWX:LLY), the current Cash Flow for Dividends is CHF-4,458 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eli Lilly and Co (XSWX:LLY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of CHF965.00 is trading 14.8% below its estimated GF Value™ of CHF1,133.11. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for XSWX:LLY:

  • Cash Flow for Dividends: CHF-4,458 Mil
  • GF Value™: CHF1,133.11 vs. price of CHF965.00 (14.8% below fair value)
  • GF Score™: 99/100 with 5 warning signs

No single metric tells the full story. See the XSWX:LLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
99GF Score

Get the complete analysis for XSWX:LLY

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF965.00
Price
CHF1,133.11
GF Value